STAAR Surgical Files Proxy Materials

TL;DR

STAAR Surgical filed proxy materials on 12/16, no fee, standard procedure.

AI Summary

STAAR Surgical Company filed a Definitive Additional Materials (DEFA14A) on December 16, 2025, containing a press release issued on December 15, 2025. This filing is related to the company's proxy statement and does not involve a fee. The company is incorporated in Delaware and its fiscal year ends on December 27.

Why It Matters

This filing indicates that STAAR Surgical Company is providing additional materials related to its proxy statement, which is a crucial document for shareholder voting and corporate governance.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement update and does not contain information suggesting immediate financial or operational risks.

Key Numbers

• 12/16/2025 — Filing Date (Date of DEFA14A filing)
• 12/15/2025 — Press Release Date (Date of press release included in filing)

Key Players & Entities

• STAAR Surgical Company (company) — Registrant
• STAAR (company) — Abbreviation for STAAR Surgical Company
• 0000718937 (company) — Central Index Key
• DE (company) — State of Incorporation
• 1227 (company) — Fiscal Year End
• 1911 Walker Ave (company) — Business Address Street 1
• Monrovia (company) — Business Address City
• CA (company) — Business Address State
• 91016 (company) — Business Address Zip
• 6263037902 (company) — Business Phone

FAQ

Key Financial Figures

• $30.75 — ith a price at or above Alcon's offered $30.75 per share. 1 Permission to use quotat

Filing Documents

• d41573ddefa14a.htm (DEFA14A) — 26KB
• g41573g1216050138412.jpg (GRAPHIC) — 3KB
• 0001193125-25-319626.txt ( ) — 32KB

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possibility that STAAR's stock p

View Full Filing

View this DEFA14A filing on SEC EDGAR